Vident Advisory, LLC 10x Genomics, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 11,999 shares of TXG stock, worth $235,300. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,999
Previous 7,828
53.28%
Holding current value
$235,300
Previous $294 Million
20.56%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$200 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$183 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$125 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$121 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$120 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.86B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...